Literature DB >> 9728286

Crying in the first year of life: good news in the midst of distress.

R G Barr1.   

Abstract

Excessive crying and colic in the first 3 months of life remain as mysterious and unsolved clinical problems. The mystery is contributed to by the relative lack of long-term follow-up studies. The findings from four new follow-up studies of infants with prior colic are analyzed in an attempt to derive a clearer picture of what 'life after colic' might be like for parents, infants, and their interactions. The bad news is that, for a subgroup of infants and parents, especially those with substantial additional risk factors, early excessive crying may not resolve, but evolve into a more generalized 'persistent mother-infant distress' syndrome. For some mothers of infants with colic, the risk of depressive symptoms or decreased self-efficacy may be increased. However, there appears to be good news for a substantial majority of infants with colic and for their parents. This includes a significant reduction over time in the amount of crying, intact parental and infant capacities to be responsive in interactive contexts, no significant maternal stress, and normal attachment relationships.

Entities:  

Mesh:

Year:  1998        PMID: 9728286     DOI: 10.1046/j.1365-2214.2002.00092.x

Source DB:  PubMed          Journal:  Child Care Health Dev        ISSN: 0305-1862            Impact factor:   2.508


  3 in total

1.  Fetal growth and infantile colic.

Authors:  C Søndergaard; E Skajaa; T B Henriksen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-07       Impact factor: 5.747

2.  Parental selection of vocal behavior : Crying, cooing, babbling, and the evolution of language.

Authors:  John L Locke
Journal:  Hum Nat       Date:  2006-06

3.  Effect of excessive infant crying on resting BP, HRV and cardiac autonomic control in childhood.

Authors:  Laetitia J C A Smarius; Manon van Eijsden; Thea G A Strieder; Theo A H Doreleijers; Reinoud J B J Gemke; Tanja G M Vrijkotte; Susanne R de Rooij
Journal:  PLoS One       Date:  2018-05-31       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.